Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02399163 · ClinicalTrials.gov registry record · NA

Evaluation of Oral Hygiene Products in an In Situ Caries Model

A NA study, sponsored by GlaxoSmithKline.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT02399163 is a NA study that has completed, run by GlaxoSmithKline. The registered enrollment target is 80 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02399163, a NA study, has completed, sponsored by GlaxoSmithKline.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

The study will evaluate and compare the potential anti-caries efficacy of a test regimen: placebo (fluoride free) toothpaste (twice daily use) plus fluoride mouthwash (once daily use), in comparison with brushing with a placebo toothpaste alone (twice daily use), to remineralize previously demineralized enamel specimens, as measured by Surface MicroHardness Recovery (%SMHR). This will be a single center, randomized, laboratory analyst blinded, placebo, four treatment, cross-over study in healthy participants. Participants will be assessed at baseline and at the beginning and end of each treatment visit to monitor clinical efficacy and safety.

Interventions

  • DRUG Fluoride toothpaste
  • DRUG Fluoride mouthwash
  • DRUG Fluoride free toothpaste

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2015-04
Est. Completion 2015-08
Phase NA

Sponsor

GlaxoSmithKline

1,345 total trials

What the Registry Record Tells You About NCT02399163

The ClinicalTrials.gov registry entry for NCT02399163 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Fluoride toothpaste is the first listed.

NCT02399163 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02399163 about?

NCT02399163 is a clinical study titled "Evaluation of Oral Hygiene Products in an In Situ Caries Model". The study will evaluate and compare the potential anti-caries efficacy of a test regimen: placebo (fluoride free) toothpaste (twice daily use) plus fluoride mouthwash (once daily use), in comparison with brushing with a placebo toothpaste alone (twice daily use), to remineralize previously demineral...

What is the current status of trial NCT02399163?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2015-04. Estimated completion is 2015-08.

What interventions are being tested in trial NCT02399163?

The interventions under investigation include: Fluoride toothpaste (DRUG), Fluoride mouthwash (DRUG), Fluoride free toothpaste (DRUG).

Who is sponsoring clinical trial NCT02399163?

This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.